Bio-Rad Laboratories, Inc. (BIO)
NYSE: BIO · Real-Time Price · USD
342.64
-5.22 (-1.50%)
Aug 6, 2026, 4:00 PM EDT - Market closed
Bio-Rad Laboratories Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 9,179 | 8,178 | 9,202 | 9,208 | 12,445 | 22,616 | |
Market Cap Growth | 22.54% | -11.13% | -0.07% | -26.01% | -44.97% | 30.00% |
Enterprise Value | 8,918 | 8,022 | 8,912 | 9,001 | 12,037 | 21,964 |
Last Close Price | 342.64 | 302.99 | 328.51 | 322.89 | 420.49 | 755.57 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 42.14 | 10.88 | - | - | - | 5.37 |
Forward PE | 33.76 | 28.94 | 28.85 | 26.51 | 28.66 | 59.87 |
PEG Ratio | - | 2.29 | 2.40 | 6.63 | 2.71 | 4.28 |
PS Ratio | 3.54 | 3.17 | 3.59 | 3.45 | 4.44 | 7.74 |
PB Ratio | 1.30 | 1.10 | 1.40 | 1.05 | 1.29 | 1.65 |
P/TBV Ratio | 1.43 | 1.23 | 1.58 | 1.18 | 1.41 | 1.74 |
P/FCF Ratio | 25.96 | 21.83 | 31.77 | 42.20 | 152.51 | 42.22 |
P/OCF Ratio | 18.61 | 15.37 | 20.22 | 24.56 | 64.02 | 33.78 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 3.44 | 3.11 | 3.47 | 3.37 | 4.30 | 7.52 |
EV/EBITDA Ratio | 40.21 | 37.73 | 21.19 | 18.61 | 24.94 | 43.90 |
EV/EBIT Ratio | 167.94 | 169.96 | 33.13 | 26.65 | 24.94 | 43.90 |
EV/FCF Ratio | 25.26 | 21.41 | 30.77 | 41.25 | 147.51 | 41.00 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.13 | 0.18 | 0.20 | 0.16 | 0.14 | 0.01 |
Debt / EBITDA Ratio | 6.18 | 6.51 | 3.27 | 2.91 | 2.88 | 0.45 |
Debt / FCF Ratio | 3.88 | 3.70 | 4.75 | 6.44 | 17.01 | 0.42 |
Net Debt / Equity Ratio | -0.04 | -0.02 | -0.04 | -0.02 | -0.04 | -0.05 |
Net Debt / EBITDA Ratio | -1.12 | -0.73 | -0.69 | -0.43 | -0.85 | -1.30 |
Net Debt / FCF Ratio | -0.70 | -0.42 | -1.00 | -0.95 | -5.00 | -1.22 |
Asset Turnover | 0.25 | 0.26 | 0.24 | 0.21 | 0.18 | 0.19 |
Inventory Turnover | 1.64 | 1.66 | 1.54 | 1.66 | 1.91 | 2.15 |
Quick Ratio | 2.14 | 3.87 | 4.53 | 4.02 | 4.03 | 1.91 |
Current Ratio | 3.14 | 5.62 | 6.48 | 5.83 | 5.55 | 2.92 |
Return on Equity (ROE) | 3.04% | 10.84% | -24.09% | -6.94% | -31.14% | 36.11% |
Return on Assets (ROA) | 0.32% | 0.36% | 1.96% | 1.96% | 2.38% | 2.54% |
Return on Invested Capital (ROIC) | 0.50% | 0.53% | 2.86% | 2.85% | 3.35% | 3.53% |
Return on Capital Employed (ROCE) | 0.55% | 0.50% | 2.60% | 2.73% | 3.21% | 3.40% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 2.43% | 9.19% | - | - | - | 18.64% |
FCF Yield | 3.85% | 4.58% | 3.15% | 2.37% | 0.66% | 2.37% |
Buyback Yield / Dilution | 3.11% | 3.31% | 3.41% | 1.93% | 1.40% | -0.16% |
Total Shareholder Return | 3.11% | 3.31% | 3.41% | 1.93% | 1.40% | -0.16% |